Published in J Alzheimers Dis on January 01, 2014
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet (2014) 1.56
The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease. Curr Alzheimer Res (2016) 0.89
Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease. J Neural Transm (Vienna) (2015) 0.79
Enhanced susceptibility of triple transgenic Alzheimer's disease (3xTg-AD) mice to acute infection. J Neuroinflammation (2017) 0.77
Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice. Mol Ther (2017) 0.77
Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model. Sci Rep (2015) 0.76
Behavioral Phenotyping of Murine Disease Models with the Integrated Behavioral Station (INBEST). J Vis Exp (2015) 0.75
Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications. J Biomed Res (2016) 0.75
Sustained Immunosuppression Alters Olfactory Function in the MRL Model of CNS Lupus. J Neuroimmune Pharmacol (2017) 0.75
Immune-mediated processes in neurodegeneration: where do we stand? J Neurol (2016) 0.75
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron (2003) 14.03
Alzheimer's disease. N Engl J Med (2010) 13.13
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
Structure and function of the spleen. Nat Rev Immunol (2005) 6.38
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron (2005) 6.20
Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (2011) 5.87
Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev (2001) 5.51
Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol (2006) 5.22
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest (1987) 4.98
Inflammation in neurodegenerative disease--a double-edged sword. Neuron (2002) 4.95
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci (2000) 4.14
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging (2003) 3.83
Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol (2008) 3.65
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54
Spontaneous auto-immune disease in NZB/BL mice. Br J Haematol (1963) 3.53
Microglia: scapegoat, saboteur, or something else? Science (2013) 2.94
Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron (1996) 2.89
The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev (2002) 2.81
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem (2005) 2.56
Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry (2007) 2.41
T-maze alternation in the rodent. Nat Protoc (2006) 2.38
Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med (2012) 2.36
Anti-inflammatory drugs and Alzheimer disease. Lancet (1990) 2.31
Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry (2013) 2.23
The blood-brain barrier and immune function and dysfunction. Neurobiol Dis (2009) 2.08
Simple behavioral assessment of mouse olfaction. Curr Protoc Neurosci (2009) 1.90
Modern flow cytometry: a practical approach. Clin Lab Med (2007) 1.89
Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc (2013) 1.69
Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis (2010) 1.68
Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci (2012) 1.67
Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev (2005) 1.65
Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.62
Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord (2007) 1.61
Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res (2008) 1.51
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci U S A (2005) 1.51
Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology (2011) 1.48
Distinct patterns of antiamyloid-β antibodies in typical and atypical Alzheimer disease. Arch Neurol (2012) 1.44
Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice. BMC Neurosci (2008) 1.44
Metals and Alzheimer's disease. J Alzheimers Dis (2006) 1.39
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol (2006) 1.38
Understanding immunity requires more than immunology. Nat Immunol (2010) 1.38
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation (2012) 1.36
Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. J Immunol (2010) 1.34
The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J Am Geriatr Soc (1996) 1.33
Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J Neurosci (2013) 1.32
CD3+CD4-CD8- (double negative) T cells: saviours or villains of the immune response? Biochem Pharmacol (2011) 1.31
Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol Scand Suppl (2003) 1.30
Spatial navigation deficit in amnestic mild cognitive impairment. Proc Natl Acad Sci U S A (2007) 1.30
Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis (2009) 1.29
Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. Biol Psychiatry (2009) 1.25
Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev (2006) 1.22
Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiol Aging (2004) 1.22
Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem (2007) 1.22
Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behav Neurosci (2001) 1.22
Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry (2003) 1.20
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. Can J Neurol Sci (2012) 1.15
Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev (1992) 1.14
Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J Alzheimers Dis (2011) 1.13
Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun Rev (2011) 1.13
ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. J Neurosci (2009) 1.12
Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement Geriatr Cogn Disord (2011) 1.12
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development. Neuromolecular Med (2003) 1.11
Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept). J Neurosci (2011) 1.11
Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 1.10
A new glucocorticoid hypothesis of brain aging: implications for Alzheimer's disease. Curr Alzheimer Res (2007) 1.10
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain (2008) 1.10
A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun (1992) 1.08
Frontal cortex neuropathology in dementia pugilistica. J Neurotrauma (2012) 1.08
Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol (2011) 1.07
Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes. Brain Res (2010) 1.07
Inflammation in transgenic mouse models of neurodegenerative disorders. Biochim Biophys Acta (2009) 1.01
Disturbed emotionality in autoimmune MRL-lpr mice. Physiol Behav (1994) 1.00
Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration. J Alzheimers Dis (2007) 0.98
Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull (1997) 0.95
Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res (2003) 0.94
Factor structure of a modified version of the wisconsin card sorting test: an analysis of executive deficit in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2003) 0.94
Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology. Brain Res Brain Res Rev (2005) 0.94
Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease. Infect Immun (2010) 0.92
Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects. Neurosci Lett (2006) 0.91
Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res Bull (1996) 0.90
Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease. MAbs (2013) 0.89
CD4 T cells in immunity and immunotherapy of Alzheimer's disease. Immunology (2013) 0.89
Olfactory bulb removal vs peripherally induced anosmia: differential effects on the aggressive behavior of male mice. Behav Biol (1972) 0.89
Humoral immunity in brain aging and Alzheimer's disease. Brain Res Brain Res Rev (2004) 0.86
Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli. Neurosci Biobehav Rev (1999) 0.86
The neurobiology of Alzheimer disease defined by neuroimaging. Curr Opin Neurol (2012) 0.86
Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice. J Autoimmun (1995) 0.84
Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model. Behav Neurosci (2009) 0.83
Neuroendocrine asymmetry. Front Neuroendocrinol (1997) 0.83
3xTg-AD mice exhibit an activated central stress axis during early-stage pathology. J Alzheimers Dis (2013) 0.82
Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment. Transl Psychiatry (2013) 0.82
Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients. PLoS One (2013) 0.82
T-lymphocyte subset distribution in human spleen. Eur J Clin Invest (2006) 0.82
Anti-inflammatory drugs and Alzheimer-type pathology in aging. Neurology (2000) 0.81
Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma. Ann Neurol (2000) 0.81
A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis. J Alzheimers Dis (2016) 0.75
Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling. Acta Neuropathol Commun (2017) 0.75
Sustained Immunosuppression Alters Olfactory Function in the MRL Model of CNS Lupus. J Neuroimmune Pharmacol (2017) 0.75